{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:59:19Z","timestamp":1791233959684,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.urolonc.2010.02.010","type":"journal-article","created":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T06:22:32Z","timestamp":1273213352000},"page":"145-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Tumor cytoreduction results in better response to androgen ablation\u2014a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer"],"prefix":"10.1016","volume":"30","author":[{"given":"Xiao-Jian","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Guang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Dong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Hai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2010.02.010_bib1","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/01.ju.0000104845.24632.92","article-title":"Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer","volume":"171","author":"Crain","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/cncr.24064","article-title":"Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy","volume":"115","author":"Choueiri","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2010.02.010_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eururo.2007.09.002","article-title":"EAU Guidelines on Prostate Cancer","volume":"53","author":"Heidenreich","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jjco\/hyh001","volume":"34","author":"Akaza","year":"2004","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1464-410x.2004.04803.x","article-title":"A reassessment of the role of combined androgen blockade for advanced prostate cancer","volume":"93","author":"Klotz","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2010.02.010_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/01.ju.0000152394.32858.14","article-title":"Salvage surgery for bulky local recurrence of prostate cancer following radical prostatectomy","volume":"173","author":"Leibovici","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib7","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ju.0000181826.65272.7b","article-title":"Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer","volume":"174","author":"Leibovici","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/1097-0142(19880715)62:2<440::AID-CNCR2820620232>3.0.CO;2-N","article-title":"Palliative surgery for gastric cancer","volume":"62","author":"Hallissey","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2010.02.010_bib9","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1200\/JCO.2004.10.218","article-title":"Use of surgery among elderly patients with stage IV colorectal cancer","volume":"22","author":"Temple","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib10","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1200\/JCO.2005.04.2226","article-title":"Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis","volume":"24","author":"Rapiti","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib11","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa003013","article-title":"Nephrectomy followed by interferon \u03b1-2b compared with interferon \u03b1-2b alone for metastatic renal-cell cancer","volume":"345","author":"Flanigan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2010.02.010_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1464-410X.2005.05394.x","article-title":"Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate specific antigen testing: 15-Year outcome","volume":"95","author":"Ward","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2010.02.010_bib13","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/cncr.21926","article-title":"Radical prostatectomy for clinical T4 prostate cancer","volume":"106","author":"Johnstone","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2010.02.010_bib14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0022-5347(01)61640-9","article-title":"Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: A matched comparison","volume":"161","author":"Ghavamian","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.ju.0000132412.74468.57","article-title":"Failure after primary radiation or surgery for prostate cancer: Differences in response to androgen ablation","volume":"172","author":"Swanson","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib16","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0022-5347(05)64562-4","article-title":"Impact of previous local treatment for prostate cancer on subsequent metastatic disease","volume":"168","author":"Thompson","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib17","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1200\/JCO.2008.19.9810","article-title":"Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: Data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916","volume":"27","author":"Hussain","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib18","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/01.ju.0000176817.46279.93","article-title":"Management of prostate cancer in China: A multicenter report of 6 institutions","volume":"174","author":"Peyromaure","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib19","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.juro.2006.06.069","article-title":"Metastatic prostate cancer\u2014does treatment of the primary tumor matter?","volume":"176","author":"Swanson","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.02.010_bib20","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1158\/0008-5472.CAN-06-3332","article-title":"Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: Therapeutic implications for castration-resistant prostate cancer","volume":"67","author":"Mostaghel","year":"2007","journal-title":"Cancer Res"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143910000517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143910000517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:58:49Z","timestamp":1761040729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143910000517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1078143910000517"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2010.02.010","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor cytoreduction results in better response to androgen ablation\u2014a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2010.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}